|Bid||106.70 x 1100|
|Ask||107.01 x 1000|
|Day's range||105.78 - 107.81|
|52-week range||91.51 - 122.16|
|Beta (5Y monthly)||0.26|
|PE ratio (TTM)||35.13|
|Forward dividend & yield||1.57 (1.46%)|
|Ex-dividend date||25 Mar 2022|
|1y target est||N/A|
Three Motley Fool contributors have identified stocks to buy and hold forever. Here's why they chose Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Eli Lilly): If you're planning to hold a stock forever, then you need to be comfortable with its growth potential.
Prothena (PRTA) incurs a loss in the second quarter while revenues miss estimates.
Novo Nordisk (NVO) missed estimates for earnings in the second quarter of 2022 while revenues beat the same, driven by growth in Diabetes and Obesity Care on higher GLP-1 revenues.